Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial showsBy Press Room20 December 2024 Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in…
Patients are so sick and tired of waiting years for a transplant that they’re signing up in droves to receive vital organs from pigsBy Press Room17 December 2024 On a farm in the southern US state of Virginia, David Ayares and his research teams are breeding genetically modified…
Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more poundsBy Press Room4 December 2024 Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables. Zepbound (tirzepatide), manufactured…